News Headlines

Display #
Pfizer receives FDA approval for SUTENT® (sunitinib malate) as first and only adjuvant treatment for adult patients at high risk of recurrent renal cell carcinoma
Discovery of a promising medication for amyotrophic lateral sclerosis (ALS)
Painful Truth: The Successful Failure Of A Biotech Startup
Negligible Benefit Of Nerlynx, A New Breast Cancer Drug, Calls For Caution
Farewell To SOAPware: The Search For A New EHR
Dogs May Be Good For The Heart, Study Finds
Level Brands' IPO Lists On The NYSE; How And Why They Switched To Regulation A+
Lab-Grown Mini Organs Could Speed Up Drug Discovery
The Rising Medicare Scams You Need To Know About
Parody Of A "Drug Commercial" Goes Viral And Propels Briteside Cannabis Company
A Brilliant And Touching Film That Turns A Little Girl's Ambition Into Our Own
Rev. Jesse Jackson In A Battle Against Parkinson's Disease
CDC: 90% Of Americans Need To Eat More Fruits And Vegetables
This Device Is The First Marketed To Treat Opioid Withdrawal, But Evidence It Works Is Lacking
Fasenra (benralizumab) receives US FDA approval for severe eosinophilic asthma
Using social media big data to combat prescription drug crisis
Spending Time With Your Grandparents May Increase Your Cancer Risk
Europe approves GSK’s new triple lung drug
Billionaire founder of Insys to plead not guilty to opioid bribe scheme
Doctors Are Still Prescribing Codeine For Kids After Tonsillectomies, Despite FDA Warning
FDA announces comprehensive regenerative medicine policy framework
Oscar Health Finances Improve Ahead Of Obamacare Expansion
CMS Administrator Seema Verma To Outline Her Plan At 2017 Forbes Healthcare Summit
FDA approves Roche hemophilia drug Hemlibra
Study Reveals Possible Connection Between High Fructose Corn Syrup And Opioid Addiction
Kendall Square Startup Cue Biopharma Scores $374 Million R&D Pact With Merck
All Systems Go: Johnson & Johnson Reaches Out for Second Ionis GI Drug
Merit Medical Coughs Up $100 Million for Bard, BD’s Biopsy Assets
Painful Truth: Successful Failure Of A Biotech Startup
Burdened By High Medication Costs? Your Boss May Be Able To Help